David Shaw’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

David Shaw’s Portfolio MR Stock Details MR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-953,465	Closed	-$25.9M	–	4041
2015 Q4	$25.9M	Buy	953,465 +230,998	+32%	+$5.95M	0.04%	529
2015 Q3	$15.8M	Sell	722,467 -83,255	-10%	-$2.12M	0.02%	722
2015 Q2	$23M	Buy	805,722 +60,312	+8%	+$1.76M	0.03%	592
2015 Q1	$20.4M	Buy	745,410 +351,402	+89%	+$9.68M	0.03%	590
2014 Q4	$10.4M	Buy	394,008 +347,708	+751%	+$10.2M	0.01%	1083
2014 Q3	$1.4M	Buy	+46,300	New	+$1.43M	﹤0.01%	2528
2014 Q2	–	Sell	-45,439	Closed	-$1.47M	–	4806
2014 Q1	$1.47M	Buy	+45,439	New	+$1.59M	﹤0.01%	2684
2013 Q4	–	Sell	-6,832	Closed	-$266K	–	4860
2013 Q3	$266K	Buy	+6,832	New	+$275K	﹤0.01%	3951

Other funds holding MR

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

David Shaw's MR Position: Q1 2016 in Review

David Shaw sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 953,465 shares — an estimated $25.9M sold.

David Shaw first reported a position in MR in Q3 2013 and held it in 8 quarters. The position peaked at $25.9M in Q4 2015. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

David Shaw reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
David Shaw sold 953,465 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $25.9M.
David Shaw first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q3 2013 and held it in 8 quarters.
David Shaw's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $25.9M in Q4 2015.
2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.